Praktické lékárenství – 3E/2021

www.praktickelekarenstvi.cz / Prakt. lékáren. 2021; 17(e3): e44–e48 / PRAKTICKÉ LÉKÁRENSTVÍ e48 FYTOTERAPIE Kurkumin – co už víme a co je nadějné LITERATURA 1. Opletal L. Přírodní látky a jejich biologická aktivita. Nutraceutika: primární metabolity a látky obsažené ve strukturovaných biologických systémech. Praha: Karolinum 2010: 378 s. 2. Evropská agentura pro léčivé přípravky. Curcumae longae rhizoma. Dostupné na: htt- ps://www.ema.europa.eu/en/medicines/herbal/curcumae-longae-rhizoma (citováno 20. 7. 2021). 3. Li S, Yuan W, Deng G, Wang P, Yang P, Aggarwal BB. Chemical composition and produ- ct quality control of turmeric (Curcuma longa L.). Pharmaceutical Crops 2011; 2(1): 28–54. 4. Hewlings SJ, Kalman DS. Curcumin: A Review of Its‘ Effects on Human Health. Foods 2017; 6(10). 5. Filardi T, Vari R, Ferretti E, Zicari A, Morano S, Santangelo C. Curcumin: Could This Com- pound Be Useful in Pregnancy and Pregnancy-Related Complications? Nutrients 2020; 12(10). 6. Hosseini A, Hosseinzadeh H. Antidotal or protective effects of Curcuma longa (turme- ric) and its active ingredient, curcumin, against natural and chemical toxicities: A review. Biomedicine 2018; 99: 411–421. 7. Opletal L. Přírodní látky a jejich biologická aktivita. Nutraceutika: sekundární metabolity rostlin. Praha: Karolinum 2016: 698 s. 8. Petrohilos S. Curcumin and depression: A literature review. Journal of the Australian – Traditional Medicine Society 2017; 23(2): 88–93. 9. Ghaneifar Z, Yousefi Z, Tajik F, Nikfar B, Ghalibafan F, Abdollahi E a Momtazi-Borojeni AB. The potential therapeutic effects of curcumin on pregnancy complications: Novel insights into reproductive medicine. IUBMB Life 2020; 72(12): 2572–2583. 10. Pasparakis M. Regulation of tissue homeostasis by NF-κB signalling: Implications for in- flammatory diseases. Nature Reviews Immunology 2009; 9: 778–788. 11. Tossetta G, Fantone S, Giannubilo SR, Marzioni D. The Multifaced Actions of Curcumin in Pregnancy Outcome. Antioxidants (Basel) 2021; 10(1): 126. 12. Babaei F, Nassiri-Asl M, Hosseinzadeh H. Curcumin (a constituent of turmeric): New tre- atment option against COVID-19. Food Science & Nutrition 2020; 8(10): 5215–5227. 13. Gupta H, Gupta M, Bhargava S. Potential use of turmeric in COVID-19. Clinical and Ex- perimental Dermatology 2020; 45(7): 902–903. 14. Rocha FAC, Assis MR. Curcumin as a potential treatment for COVID-19. Phytotherapy Research 2020; 34(9): 2085–2087. 15. Soni VK, Mehta A, Ratre YK, Tiwari AK, Amit A, Singh RP, Sonkar SC, Chaturvedi N, Shu- kla D, Vishvakarma NK. Curcumin, a traditional spice component, can hold the promise against COVID-19? European Journal of Pharmacology 2020; 886: 173551. 16. Rattis BAC, Ramos SG, Celes MRN. Curcumin as a Potential Treatment for COVID-19. Fron- tiers in Pharmacology 2021; 12: 675287. 17. Thimmulappa RK, Mudnakudu-Nagaraju KK, Shivamallu C, Subramaniam KJT, Radhakris- hnan A, Bhojraj S, Kuppusamy G. Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19. Heliyon 2021; 7(2): e06350. 18. Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, Aggarwal BB. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Bri- tish Journal of Pharmacology 2017;174(11): 1325–1348. 19. Evropská agentura pro léčivé přípravky. European Union herbal monograph on Curcu- ma longa L., rhizoma. Dostupné na: https://www.ema.europa.eu/en/documents/herbal- -monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revisi- on-1_en.pdf (citováno 20. 7. 2021) 20. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and ca- ncer: an “old-age” disease with an “age-old” solution. Cancer Letters 2008; 267: 133–164. 21. Rasyid A, Rahman ARA, Jaalam K, Lelo A. Effect of different curcumin dosages on hu- man gall bladder. Asia Pacific journal of clinical nutrition 2002; 11: 314–318.